Comparison of the Effects of DOTA and NOTA Chelators on <sup>64</sup>Cu-Cudotadipep and <sup>64</sup>Cu-Cunotadipep for Prostate Cancer
Background: This study compared the effects of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) as <sup>64</sup>Cu-chelating agents in newly developed prostate-specific membrane antigen (PSMA) target compounds, <su...
Main Authors: | Inki Lee, Min Hwan Kim, Kyongkyu Lee, Keumrok Oh, Hyunwoo Lim, Jae Hun Ahn, Yong Jin Lee, Gi Jeong Cheon, Dae Yoon Chi, Sang Moo Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/16/2649 |
Similar Items
-
Radionuclide Cisternography with [<sup>64</sup>Cu]Cu-DOTA
by: Julia Greiser, et al.
Published: (2023-09-01) -
Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the <sup>64</sup>Cu-Labelling of Immunoconjugates
by: Aurélie Maisonial-Besset, et al.
Published: (2022-12-01) -
A High-Affinity <sup>64</sup>Cu-Labeled Ligand for PET Imaging of Hepsin: Design, Synthesis, and Characterization
by: Ji-Hun Park, et al.
Published: (2022-09-01) -
<sup>64</sup>Cu-DOTHA<sub>2</sub>-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window
by: Marie-Christine Milot, et al.
Published: (2022-08-01) -
Recent Advances in <sup>64</sup>Cu/<sup>67</sup>Cu-Based Radiopharmaceuticals
by: Olga O. Krasnovskaya, et al.
Published: (2023-05-01)